Ocular manifestations of pituitary adenomas.
Fifty patients with pituitary adenomas were evaluated preoperatively by an ophthalmologist; of these, 68% had visual field defects, the most common (25%) a superior bitemporal depression and 16%, bitemporal hemianopsia. Almost 60% of patients with field defects had visual complaints; 38% had visual acuity in one eye of 20/60 or less. Patients with larger, nonsecreting tumors had more visual defects than patients with secreting pituitary adenomas.
D000236:Adenoma / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism; D000239:Adenoma, Acidophil / Q000150:complications; D000238:Adenoma, Chromophobe / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000367:Age Factors; D000368:Aged; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006423:Hemianopsia / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism; D011388:Prolactin / Q000097:blood; D014057:Tomography, X-Ray Computed; D014786:Vision Disorders / Q000209:etiology*; D014792:Visual Acuity; D014794:Visual Fields
D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone